Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 1
1967 2
1968 5
1969 6
1970 8
1971 4
1972 11
1973 6
1974 4
1975 7
1976 6
1977 8
1978 6
1979 3
1980 3
1981 5
1982 8
1983 4
1984 3
1985 6
1986 3
1987 1
1988 6
1989 9
1990 6
1991 10
1992 12
1993 14
1994 21
1995 22
1996 18
1997 24
1998 21
1999 13
2000 14
2001 26
2002 27
2003 29
2004 24
2005 28
2006 28
2007 30
2008 30
2009 28
2010 31
2011 28
2012 26
2013 37
2014 40
2015 50
2016 40
2017 34
2018 32
2019 34
2020 38
2021 33
2022 24
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

954 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG. Stirnemann J, et al. Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441. Int J Mol Sci. 2017. PMID: 28218669 Free PMC article. Review.
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. ...Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whe
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. ...Type-1 Gaucher disease
[Gaucher disease: A review].
Nguyen Y, Stirnemann J, Belmatoug N. Nguyen Y, et al. Rev Med Interne. 2019 May;40(5):313-322. doi: 10.1016/j.revmed.2018.11.012. Epub 2019 Jan 11. Rev Med Interne. 2019. PMID: 30638965 Review. French.
In the general population, its incidence varies between 0.4 and 5.8/100,000 inhabitants. Type 1 Gaucher disease is the most frequent and is characterized by its extreme heterogeneity including asymptomatic or more severe presentations. ...Specific treatment, …
In the general population, its incidence varies between 0.4 and 5.8/100,000 inhabitants. Type 1 Gaucher disease is the …
Gaucher Disease for Hematologists.
Özdemir GN, Gündüz E. Özdemir GN, et al. Turk J Haematol. 2022 Jun 1;39(2):136-139. doi: 10.4274/tjh.galenos.2021.2021.0683. Epub 2022 Apr 20. Turk J Haematol. 2022. PMID: 35439918 Free PMC article. Review.
Gaucher disease (GD) is a rare hereditary lysosomal storage disease that arises due to deficiency of glucocerebrosidase. ...
Gaucher disease (GD) is a rare hereditary lysosomal storage disease that arises due to deficiency of glucocerebrosidase
Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Dandana A, et al. Pathobiology. 2016;83(1):13-23. doi: 10.1159/000440865. Epub 2015 Nov 21. Pathobiology. 2016. PMID: 26588331 Free article. Review.
We present a brief review of Gaucher disease (GD), the most common lysosomal storage disease. GD is a rare autosomal recessive disorder characterized by the defective function of the catabolic enzyme beta-glucocerebrosidase (GBA), leading to an accumulation o …
We present a brief review of Gaucher disease (GD), the most common lysosomal storage disease. GD is a rare autosomal re …
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.
Daykin EC, Ryan E, Sidransky E. Daykin EC, et al. Mol Genet Metab. 2021 Feb;132(2):49-58. doi: 10.1016/j.ymgme.2021.01.002. Epub 2021 Jan 9. Mol Genet Metab. 2021. PMID: 33483255 Free PMC article. Review.
Gaucher disease (GD), resulting from biallelic mutations in the gene GBA1, is a monogenic recessively inherited Mendelian disorder with a wide range of phenotypic presentations. The more severe forms of the disease, acute neuronopathic GD (GD2) and chronic ne
Gaucher disease (GD), resulting from biallelic mutations in the gene GBA1, is a monogenic recessively inherited Mendelian diso
Update of treatment for Gaucher disease.
Kong W, Lu C, Ding Y, Meng Y. Kong W, et al. Eur J Pharmacol. 2022 Jul 5;926:175023. doi: 10.1016/j.ejphar.2022.175023. Epub 2022 May 13. Eur J Pharmacol. 2022. PMID: 35569551 Review.
Gaucher disease (GD), the most common lysosomal disorders, is a rare autosomal recessive hereditary disease that is caused by deficiency of glucosylceramidase. ...
Gaucher disease (GD), the most common lysosomal disorders, is a rare autosomal recessive hereditary disease that is cau
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches.
Riboldi GM, Di Fonzo AB. Riboldi GM, et al. Cells. 2019 Apr 19;8(4):364. doi: 10.3390/cells8040364. Cells. 2019. PMID: 31010158 Free PMC article. Review.
Parkinson's disease (PD) is the second most common degenerative disorder. Although the disease was described more than 200 years ago, its pathogenetic mechanisms have not yet been fully described. ...GBA mutations are the most common genetic risk factor of the di
Parkinson's disease (PD) is the second most common degenerative disorder. Although the disease was described more than 200 yea …
Lysosomal storage diseases.
Platt FM, d'Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Platt FM, et al. Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4. Nat Rev Dis Primers. 2018. PMID: 30275469 Review.
Consequently, the cellular pathogenesis of these diseases is complex and is currently incompletely understood. Several LSDs can be treated with approved, disease-specific therapies that are mostly based on enzyme replacement. ...
Consequently, the cellular pathogenesis of these diseases is complex and is currently incompletely understood. Several LSDs can be treated w …
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Weinreb NJ, Goker-Alpan O, Kishnani PS, Longo N, Burrow TA, Bernat JA, Gupta P, Henderson N, Pedro H, Prada CE, Vats D, Pathak RR, Wright E, Ficicioglu C. Weinreb NJ, et al. Mol Genet Metab. 2022 May;136(1):4-21. doi: 10.1016/j.ymgme.2022.03.001. Epub 2022 Mar 9. Mol Genet Metab. 2022. PMID: 35367141 Free article. Review.
Gaucher disease (GD) is an autosomal recessive inherited lysosomal storage disease that often presents in early childhood and is associated with damage to multiple organ systems. Many challenges associated with GD diagnosis and management arise from the consi
Gaucher disease (GD) is an autosomal recessive inherited lysosomal storage disease that often presents in early childho
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
Hruska KS, LaMarca ME, Scott CR, Sidransky E. Hruska KS, et al. Hum Mutat. 2008 May;29(5):567-83. doi: 10.1002/humu.20676. Hum Mutat. 2008. PMID: 18338393 Review.
Gaucher disease (GD) is an autosomal recessive disorder caused by the deficiency of glucocerebrosidase, a lysosomal enzyme that catalyses the hydrolysis of the glycolipid glucocerebroside to ceramide and glucose. ...
Gaucher disease (GD) is an autosomal recessive disorder caused by the deficiency of glucocerebrosidase, a lysosomal enzyme tha
954 results